Functional HIV-1/HCV cross-reactive antibodies isolated from a chronically co-infected donor
Open Access
- 27 January 2023
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 42 (2) , 112044
Abstract
No abstract availableKeywords
Funding Information
- Takeda Pharmaceuticals U.S.A.
- Vanderbilt University Medical Center
- Vanderbilt Digestive Diseases Research Center, Vanderbilt University Medical Center
- Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center (VR54249)
- Vanderbilt Cancer Center
- National Center for Research Resources (F30AI150077, G20 RR030956, P20DK123967, R01AI131722, R01AI152693, R01AI157155, R01AI165947, T32GM007347, T32GM007569)
- AstraZeneca
- National Center for Advancing Translational Sciences (5UL1 RR024975-03, 5ULITR002243-03)
- National Institutes of Health (DK058404, P30 CA68485, P30 EY08126)
This publication has 79 references indexed in Scilit:
- Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virusProceedings of the National Academy of Sciences, 2012
- Antibody-based protection against HIV infection by vectored immunoprophylaxisNature, 2011
- HIV/hepatitis C coinfection natural history and disease progressionCurrent Opinion in HIV and AIDS, 2011
- HIV/HCV Co-infection: Pathogenesis, Clinical Complications, Treatment, and New Therapeutic TechnologiesCurrent HIV/AIDS Reports, 2011
- Scaffolding to build a rational vaccine design strategyProceedings of the National Academy of Sciences, 2010
- Elicitation of structure-specific antibodies by epitope scaffoldsProceedings of the National Academy of Sciences, 2010
- New Algorithms and Methods to Estimate Maximum-Likelihood Phylogenies: Assessing the Performance of PhyML 3.0Systematic Biology, 2010
- Analysis of Memory B Cell Responses and Isolation of Novel Monoclonal Antibodies with Neutralizing Breadth from HIV-1-Infected IndividualsPLOS ONE, 2010
- Structural Basis of Immune Evasion at the Site of CD4 Attachment on HIV-1 gp120Science, 2009
- Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 InfectionJournal of Virology, 2009